Correlation Between Catalyst Pharmaceuticals and CROWN

Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and CROWN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and CROWN into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Catalyst Pharmaceuticals and CROWN CASTLE INTERNATIONAL, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and CROWN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of CROWN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and CROWN.

Diversification Opportunities for Catalyst Pharmaceuticals and CROWN

0.26

Correlation Coefficient

Catalyst Pharmaceuticals  CROWN

Modest diversification

The 3 months correlation between Catalyst and CROWN is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and CROWN CASTLE INTERNATIONAL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CROWN CASTLE INTERNA and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with CROWN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CROWN CASTLE INTERNA has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and CROWN go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and CROWN

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to under-perform the CROWN. In addition to that, Catalyst Pharmaceuticals is 4.15 times more volatile than CROWN CASTLE INTERNATIONAL. It trades about -0.06 of its total potential returns per unit of risk. CROWN CASTLE INTERNATIONAL is currently generating about -0.07 per unit of volatility. If you would invest  8,305  in CROWN CASTLE INTERNATIONAL on October 7, 2024 and sell it today you would lose (125.00) from holding CROWN CASTLE INTERNATIONAL or give up 1.51% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	95.12%
Values	Daily Returns

Catalyst Pharmaceuticals  vs.  CROWN CASTLE INTERNATIONAL

Catalyst Pharmaceuticals

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in February 2025.

CROWN CASTLE INTERNA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CROWN CASTLE INTERNATIONAL has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, CROWN is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Catalyst Pharmaceuticals and CROWN

The main advantage of trading using opposite Catalyst Pharmaceuticals and CROWN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, CROWN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CROWN will offset losses from the drop in CROWN's long position.

The idea behind Catalyst Pharmaceuticals and CROWN CASTLE INTERNATIONAL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.